Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes
Clinical trial NCT00807092 · COMPLETED
Trial details
- NCT number
- NCT00807092
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2009-10-01
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.